Akava Therapeutics Inc. — Form D
Akava Therapeutics Inc. of WINNETKA, IL, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-23. The offering totals $5.0M. Industry: Pharmaceuticals.
Offering
- Filed: 2024-04-23
- Form: D
- Accession: 0001966649-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Remaining: $5.0M
- Minimum investment: $100K
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-511339
Issuer
- Name: Akava Therapeutics Inc.
- CIK: 0001966649
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 755 SHERIDAN ROAD, WINNETKA, IL, 60093
- Phone: (847) 494-7434
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Joseph Nolan | Director | Lake Bluff, IL |
| Brendan MacMillan | Director | Greenwich, CT |
| Richard Silverman | Director | Winnetka, IL |
| Richard Silverman | Executive Officer | Winnetka, IL |
| Charles Polsky | Director | Chicago, IL |
| Charles Polsky | Executive Officer | Chicago, IL |
| Philip Silverman | Director | Miami, FL |
| Philip Silverman | Executive Officer | Miami, FL |
Other filings by this issuer (3)
More